Hex Code
Color name
RGB
HSL
CMYK
#F39800
Orange Peel
243, 152, 0
38, 100, 48
0, 37, 100, 5
#E4606D
Mandy
228, 96, 109
354, 71, 64
0, 58, 52, 11
#C81432
Crimson
200, 20, 50
350, 82, 43
0, 90, 75, 22
Ascletis Pharma Inc. Our mission is to meet the clinical needs of patients both domestically and internationally. With a strong focus on fatty liver disease, Ascletis aims to eliminate viral hepatitis, a major public health threat, by 2030.
Established in 2013, Ascletis Pharma Inc. As a fully-owned subsidiary of Ascletis, Gannex Pharma is dedicated to the research and commercialization of innovative drugs in the NASH field. Our innovative drug pipeline includes treatments for viral diseases, NASH/PBC, and cancer, such as the development of ASC22, a PD-L1 antibody for HBV and HIV functional cure.
Join us at Ascletis, where we provide equal development opportunities, a positive work environment, and a competitive salary and benefits package. Send your resume to hr@ascletis. com to be part of our team and help us achieve our vision of becoming a world-class biopharmaceutical company that addresses the clinical needs of patients worldwide.
Learn more at ascletis. com. © 2018 Ascletis Pharma Inc.
All Rights Reserved
Company type
Public Company
Year founded
2013
Company size
201-500 employees
Oral GLP-1 receptor agonists
Amylin receptor agonists
Long-acting peptide therapeutics
Metabolic disease drug development
Obesity and weight-management therapies
